---
title: "Sanofi: Information concerning the total number of voting rights and shares - April 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286946199.md"
description: "Sanofi has provided information regarding its total number of voting rights and shares as of April 30, 2026. The company has issued 1,212,212,936 shares, with 1,329,027,146 real voting rights (excluding treasury shares) and a theoretical total of 1,346,241,660 voting rights (including treasury shares). This information complies with French commercial regulations."
datetime: "2026-05-19T16:37:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286946199.md)
  - [en](https://longbridge.com/en/news/286946199.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286946199.md)
---

# Sanofi: Information concerning the total number of voting rights and shares - April 2026

**Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the** **_Code de commerce_** **(the French Commercial Code) and article 223-16 of the** **_Règlement général de l’Autorité des Marchés Financiers_** **(Regulation of the French stock market authority)**

Sanofi

a French _société anonyme_ with a registered share capital of €2,424,365,088

Registered office:46, avenue de la Grande Armée - 75017 Paris - France

Registered at the Paris Commercial and Companies Registry under number 395 030 844

**Date**

April 30, 2026

**Total number of** **issued shares**

1,212,212,936

**Number of real** **voting rights****(excluding treasury shares)**

1,329,027,146

**Theoretical number of** **voting rights** **(including treasury shares)\***

1,346,241,660

\* Pursuant to Article 223-11 of the _Règlement général de l’Autorité des Marchés Financiers._

This information is also available on the internet website of sanofi:

https://www.sanofi.com/en/investors/sanofi-share-and-adrs/shares-structure-vote

**Investor Relations Department**e-mail: investor.relations@sanofi.com

**Attachment**

-   EN\_number\_of\_voting\_rights\_and\_shares\_April\_2026

### Related Stocks

- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)

## Related News & Research

- [Sanofi says rare lung disease drug outperforms standard care in trial](https://longbridge.com/en/news/286810610.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET | NXXT Stock News](https://longbridge.com/en/news/286673001.md)
- [Viridien: Information on the total number of voting rights and shares  | CGG Stock News](https://longbridge.com/en/news/286126383.md)
- [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)